Show simple item record

dc.contributor.authorAst, Julia
dc.contributor.authorArvaniti, Anastasia
dc.contributor.authorFine, Nicholas H. F.
dc.contributor.authorNasteska, Daniela
dc.contributor.authorAshford, Fiona B.
dc.contributor.authorStamataki, Zania
dc.contributor.authorKoszegi, Zsombor
dc.contributor.authorBacon, Andrea
dc.contributor.authorJones, Ben J.
dc.contributor.authorLucey, Maria A.
dc.contributor.authorSasaki, Shugo
dc.contributor.authorBrierley, Daniel I.
dc.contributor.authorHastoy, Benoit
dc.contributor.authorTomas, Alejandra
dc.contributor.authorD’Agostino, Giuseppe
dc.contributor.authorReimann, Frank
dc.contributor.authorLynn, Francis C.
dc.contributor.authorReissaus, Christopher A.
dc.contributor.authorLinnemann, Amelia K.
dc.contributor.authorD’Este, Elisa
dc.contributor.authorCalebiro, Davide
dc.contributor.authorTrapp, Stefan
dc.contributor.authorJohnsson, Kai
dc.contributor.authorPodewin, Tom
dc.contributor.authorBroichhagen, Johannes
dc.contributor.authorHodson, David J.
dc.date.accessioned2021-01-23T16:11:09Z
dc.date.available2021-01-23T16:11:09Z
dc.date.issued2020-01-24
dc.date.submitted2019-02-27
dc.identifier.others41467-020-14309-w
dc.identifier.other14309
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/316627
dc.descriptionFunder: U.S. Department of Health & Human Services | National Institutes of Health (NIH)
dc.descriptionFunder: EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)); doi: https://doi.org/10.13039/100011199; Grant(s): 715884
dc.description.abstractAbstract: The glucagon-like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in metabolism. Presently, its visualization is limited to genetic manipulation, antibody detection or the use of probes that stimulate receptor activation. Herein, we present LUXendin645, a far-red fluorescent GLP1R antagonistic peptide label. LUXendin645 produces intense and specific membrane labeling throughout live and fixed tissue. GLP1R signaling can additionally be evoked when the receptor is allosterically modulated in the presence of LUXendin645. Using LUXendin645 and LUXendin651, we describe islet, brain and hESC-derived β-like cell GLP1R expression patterns, reveal higher-order GLP1R organization including membrane nanodomains, and track single receptor subpopulations. We furthermore show that the LUXendin backbone can be optimized for intravital two-photon imaging by installing a red fluorophore. Thus, our super-resolution compatible labeling probes allow visualization of endogenous GLP1R, and provide insight into class B GPCR distribution and dynamics both in vitro and in vivo.
dc.languageen
dc.publisherNature Publishing Group UK
dc.rightsAttribution 4.0 International (CC BY 4.0)en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectArticle
dc.subject/631/1647/245/2226
dc.subject/631/80/2373/2238
dc.subject/631/92/96
dc.subject/692/163/2743
dc.subject/14/69
dc.subject/14/34
dc.subject/96
dc.subject/96/33
dc.subject/96/100
dc.subject/64/60
dc.subject/13/51
dc.subject/123
dc.subject/14
dc.subject/14/19
dc.subject/14/63
dc.subject/45
dc.subject/38
dc.subject/59
dc.subjectarticle
dc.titleSuper-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics
dc.typeArticle
dc.date.updated2021-01-23T16:11:07Z
prism.issueIdentifier1
prism.publicationNameNature Communications
prism.volume11
dc.identifier.doi10.17863/CAM.63739
dcterms.dateAccepted2019-12-27
rioxxterms.versionofrecord10.1038/s41467-020-14309-w
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidAst, Julia [0000-0002-0039-4762]
dc.contributor.orcidFine, Nicholas H. F. [0000-0003-2343-8534]
dc.contributor.orcidNasteska, Daniela [0000-0002-8996-5102]
dc.contributor.orcidStamataki, Zania [0000-0003-3823-4497]
dc.contributor.orcidSasaki, Shugo [0000-0002-3696-7809]
dc.contributor.orcidBrierley, Daniel I. [0000-0002-4360-2648]
dc.contributor.orcidHastoy, Benoit [0000-0003-1244-7857]
dc.contributor.orcidD’Agostino, Giuseppe [0000-0002-3502-4251]
dc.contributor.orcidReimann, Frank [0000-0001-9399-6377]
dc.contributor.orcidLynn, Francis C. [0000-0001-9318-1063]
dc.contributor.orcidLinnemann, Amelia K. [0000-0001-7356-4876]
dc.contributor.orcidCalebiro, Davide [0000-0002-3811-1553]
dc.contributor.orcidTrapp, Stefan [0000-0003-0665-4948]
dc.contributor.orcidJohnsson, Kai [0000-0002-8002-1981]
dc.contributor.orcidPodewin, Tom [0000-0002-1632-5104]
dc.contributor.orcidBroichhagen, Johannes [0000-0003-3084-6595]
dc.contributor.orcidHodson, David J. [0000-0002-8641-8568]
dc.identifier.eissn2041-1723
pubs.funder-project-idRCUK | Medical Research Council (MRC) (MR/R010676/1, MR/R010676/1, MR/N00275X/1, MR/S025618/1)
pubs.funder-project-idGouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) (CIHR PJT 156377)
pubs.funder-project-idU.S. Department of Health & Human Services | National Institutes of Health (NIH) (UC4 DK104162, R01 DK095757)
pubs.funder-project-idWellcome Trust (Wellcome) (212313/Z/18/Z)
pubs.funder-project-idRCUK | MRC | Medical Research Foundation (MR/N02589X/1)
pubs.funder-project-idDiabetes UK (12/0004431)


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's licence is described as Attribution 4.0 International (CC BY 4.0)